Rephaiah, a research focused pharmaceutical company registered in Iceland has partnered Kamuzu University of Health Sciences (KUHeS), a leading science and medical institution in Malawi to manufacture vaccines, fluids, antibiotics and painkillers in a deal worth US$33 million (about K33 billion). Kuhes has an ambitious strategic plan of establishing a state-of-the-art manufacturing facility with over […]

The post Rephaiah partners KUHES to manufacture medicines appeared first on Malawi Nyasa Times – News from Malawi about Malawi.